FDA approves Spravato as first stand-along nasal spray to treat drug-resistant depression WXYZ 7 Action News Detroit
Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases Gizmodo
FDA approves nasal spray for treatment-resistant depression Medical Xpress
Can You Mix Lexapro and Alcohol? Two Expert Doctors Respond The Healthy
FDA approves innovative monotherapy for TR-depression European Pharmaceutical Review
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression Northeast Mississippi Daily Journal
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings Fast Company
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression The Daily Record
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression U.S. News & World Report
FDA approves first-of-its-kind nasal spray for severe depression Popular Science
